Therapies used during CF encompass drugs targeted against CF itself, encompassing two main classes of CFTR-targeting compounds: CFTR potentiators, increasing activity of CFTR on epithelial surfaces, and CFTR correctors, improving defective protein processing and trafficking [6], as well as drugs against each of the microbial infections, or co-infections. Here, CFTR is linked to coinfection.